These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2126024

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study.
    Cirkel U, Ochs H, Schneider HP, Mettler L, Mayer-Eichberger D, Schindler AE, Bühler K, Winkler U, Zahradnik HP, Künzig HJ.
    Clin Ther; 1992; 14 Suppl A():37-50. PubMed ID: 1606593
    [Abstract] [Full Text] [Related]

  • 23. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases.
    George M, Lhomme C, Lefort J, Gras C, Comaru-Schally AM, Schally AV.
    Int J Fertil; 1989; 34(1):19-24. PubMed ID: 2565299
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J, Aldrighi JM, de Lima GR.
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [Abstract] [Full Text] [Related]

  • 26. [Clinical application of luteinizing hormone releasing hormone agonist and its impact on bone metabolism].
    Zhang M, He Y, Cao S.
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):398-401. PubMed ID: 7587574
    [Abstract] [Full Text] [Related]

  • 27. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
    Andreyko JL, Blumenfeld Z, Marshall LA, Monroe SE, Hricak H, Jaffe RB.
    Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS.
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [Abstract] [Full Text] [Related]

  • 30. Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas.
    Maheux R, Lemay A, Merat P.
    Fertil Steril; 1987 Feb; 47(2):229-33. PubMed ID: 3102282
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.
    West CP, Lumsden MA, Lawson S, Williamson J, Baird DT.
    Fertil Steril; 1987 Jul; 48(1):45-51. PubMed ID: 2954863
    [Abstract] [Full Text] [Related]

  • 34. Treatment of estrogen-dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin.
    Biberoglu K, Gursoy R, Yildiz A.
    Gynecol Endocrinol; 1991 Jun; 5(2):109-22. PubMed ID: 1833953
    [Abstract] [Full Text] [Related]

  • 35. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor.
    Shozu M, Murakami K, Segawa T, Kasai T, Inoue M.
    Fertil Steril; 2003 Mar; 79(3):628-31. PubMed ID: 12620453
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V, Marquez J, Schally AV, Comaru-Schally AM, Leal G, Zacharias S, Gomez-Lira C.
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [Abstract] [Full Text] [Related]

  • 39. [Shrinkage of uterine leiomyomas after intranasal administration of a LHRH agonist].
    Uemura T, Kimura A, Shirasu K, Minaguchi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):365-8. PubMed ID: 2499643
    [No Abstract] [Full Text] [Related]

  • 40. Pre-surgical treatment of uterine myomas with LH-RH agonists.
    D'Addato F, Repinto A, Andreoli C.
    Clin Exp Obstet Gynecol; 1992 Mar; 19(1):45-50. PubMed ID: 1535032
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.